A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus

Temsirolimus is an inhibitor of mammalian target of rapamycin and interstitial lung disease (ILD) is known to be one of the adverse events associated with temsirolimus, which usually improves rapidly after discontinuation of the drug and rarely worsens thereafter. Herein, we report a case of delayed...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuki, Rei, Okuda, Kenichi, Mitani, Akihisa, Yamauchi, Yasuhiro, Tanaka, Goh, Kume, Haruki, Homma, Yukio, Hinata, Munetoshi, Hayashi, Akimasa, Shibahara, Junji, Fukayama, Masashi, Nagase, Takahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558510/
https://www.ncbi.nlm.nih.gov/pubmed/28840097
http://dx.doi.org/10.1016/j.rmcr.2017.08.008

Ejemplares similares

Ejemplares similares